Your browser doesn't support javascript.
loading
Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.
Rodríguez-Frade, José M; Guedán, Anabel; Lucas, Pilar; Martínez-Muñoz, Laura; Villares, Ricardo; Criado, Gabriel; Balomenos, Dimitri; Reyburn, Hugh T; Mellado, Mario.
Afiliação
  • Rodríguez-Frade JM; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Guedán A; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Lucas P; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Martínez-Muñoz L; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Villares R; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Criado G; Inflammatory and Autoimmune Diseases Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.
  • Balomenos D; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Reyburn HT; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
  • Mellado M; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
Front Immunol ; 8: 460, 2017.
Article em En | MEDLINE | ID: mdl-28484458
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha